Allergan (AGN) Declares $0.72 Quarterly Dividend; 1.6% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Wall St subdued in choppy trade after big bank earnings, chips slide
- Oil prices ease as US-Russia diesel deal hopes offset Middle East attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
- Bausch + Lomb names Appio interim CEO as Saunders departs
- Cerebras Systems hits new 52-week low on unlock concerns
- Getty Images to go private via prepackaged Chapter 11 restructuring
- CoreWeave stock drops on insider selling notice
- Sysco calls on Teamsters to end LA strike after economic deal reached
Allergan (AGN) Tops Q3 EPS by 18c, Revenues Beat; Lifts FY18 Revenue Guidance Outlook
October 30, 2018 6:33 AM EDTAllergan (NYSE: AGN) reported Q3 EPS of $4.15, $0.18 better than the analyst estimate of $3.97. Revenue for the quarter came in at $4.03 billion versus the consensus estimate of $3.82 billion.
"Allergan's performance in the third quarter of 2018 highlights the momentum in our business and our focus on execution. We continued to deliver solid results in the third quarter, driven by double-digit growth from many of our key... More
Allergen (AGN) PT Raised to $220 at RBC Capital
October 24, 2018 6:49 AM EDTRBC Capital analyst Randall Stanicky raised the price target on Allergen (NYSE: AGN) to $220.00 (from $213.00) while maintaining a Outperform rating.
Stanicky looks at three main themes relative to the current set-up:
(1) We expect a formal shift from strategic focus to pipeline; several important 2019... More



